Not applicableStudy completedNCT03694769What this trial is testingInvestigating Drop AttacksWho this might be right forFunctional Disorder University of Edinburgh 7
Large-scale testing (Phase 3)Ended earlyNCT05288283What this trial is testingEfficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic SeizuresWho this might be right forSeizures Associated With EMAS Jazz Pharmaceuticals 3
Large-scale testing (Phase 3)Study completedNCT01160770What this trial is testingSafety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut SyndromeWho this might be right forLennox-Gastaut Syndrome Lundbeck LLC 267
Testing effectiveness (Phase 2)Study completedNCT03650452What this trial is testingA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesWho this might be right forEpilepsyDravet SyndromeLennox-Gastaut Syndrome Takeda 141
Not applicableStudy completedNCT03443388What this trial is testingNovel Helmet Design in Patients With SeizuresWho this might be right forDrug Resistant EpilepsyDrop SeizuresGeneralized Tonic Clonic Seizure+2 more Michael A. Gelfand, MD, PhD 9
Large-scale testing (Phase 3)Study completedNCT00518713What this trial is testingClobazam in Patients With Lennox-Gastaut SyndromeWho this might be right forEpilepsyEpilepsy, GeneralizedSeizures Lundbeck LLC 238